Inhibition of angiogenesis in cancer by iNOS antisense oligodeoxynucleotide
Jie ZHANG,cai-cun ZHOU,Bo SU,Rong-xuan ZHANG,Ai-wu LI,Mo CHEN,Jie KONG,Hui ZHENG
DOI: https://doi.org/10.3969/j.issn.1673-5269.2006.06.006
2006-01-01
Abstract:OBJESTIVE:To investigate the effect of antiangiogenic activity induced by iNOS antisense oligodeoxynucleotide(AS-ODN). METHODS:A549 cell was transfected with a synthetic of oligodeoxynucleotide complementary to the beginning region of translation of iNOS. Then the production of NO was measured. AS-ODN and its control sequences, mismatch oligodeoxynucleotide(Mis-ODN) and saline solution were delivered into nude mice intraperitoneally at day 1, 4, 7, 12,18after A549 tumor cell implantation. On day 10 the mice were sacrificed and wight of tumors were measured. Microvessel density(MVD) and expression of vascular endothelial growth factor(VEGF) was detected via immumohistochemistry method. RESULTS:NO of AS-ODN group was lower than that of Mis-ODN and in saline solution group in a time-dependent and dose-dependent manner. Weight of tumor in AS-ODN was lower than that in Mis-ODN and saline solution group,F=3.24,3.89, P=0.044,0.032.MVD of AS-ODN group, Mis-ODN group, and saline solution group were 6.9± 3.2,11.8±6.8, and 12.9±5.4, respectively, F=5.53,7.63,P=0.006,0.001; Positive expression rate of VEGF protein in ASODN treated mice was significantly lower than those treated by Mis-ODN, u=-2.457,P=0.017. CONCLUSIONS:iNOS AS-ODN can reduce the production of NO in tumor cells, down-regulate expression of VEGF and suppress angiogenesis in vivo.